Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Preisser

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Current Oncology (Toronto, Ont.)|December 13, 2021
Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical ProstatectomyBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Frontiers in Surgery|March 15, 2021
Multiparametric MRI may Help to Identify Patients With Prostate Cancer in a Contemporary Cohort of Patients With Clinical Bladder Outlet Obstruction Scheduled for Holmium Laser Enucleation of the Prostate (HoLEP)Mike Wenzel, Maria N Welte, Lina Grossmann, et al.
Medicina (Kaunas, Lithuania)|June 28, 2023
Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Clara Humke, et al.
European Urology Oncology|February 22, 2023
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical ReviewFrancesco Mattana, Lorenzo Muraglia, Pawel Rajwa, et al.
European Urology Focus|December 28, 2020
Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate BiopsyMike Wenzel, Maria N Welte, Lena H Theissen, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision MakingPhilipp Mandel, Mike Wenzel, Benedikt Hoeh, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Urethral Sphincter Length but Not Prostatic Apex Shape in Preoperative MRI Is Associated with Mid-Term Continence Rates after Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Matthias Müller, et al.
Central European Journal of Urology|November 3, 2021
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional studyFabio Zattoni, Giancarlo Marra, Alexander Kretschmer, et al.
International Urology and Nephrology|February 19, 2021
Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomyMike Wenzel, Felix Preisser, Matthias Mueller, et al.
Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Current Oncology (Toronto, Ont.)|December 13, 2021
Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical ProstatectomyBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Frontiers in Surgery|March 15, 2021
Multiparametric MRI may Help to Identify Patients With Prostate Cancer in a Contemporary Cohort of Patients With Clinical Bladder Outlet Obstruction Scheduled for Holmium Laser Enucleation of the Prostate (HoLEP)Mike Wenzel, Maria N Welte, Lina Grossmann, et al.
Medicina (Kaunas, Lithuania)|June 28, 2023
Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Clara Humke, et al.
European Urology Oncology|February 22, 2023
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical ReviewFrancesco Mattana, Lorenzo Muraglia, Pawel Rajwa, et al.
European Urology Focus|December 28, 2020
Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate BiopsyMike Wenzel, Maria N Welte, Lena H Theissen, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision MakingPhilipp Mandel, Mike Wenzel, Benedikt Hoeh, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Urethral Sphincter Length but Not Prostatic Apex Shape in Preoperative MRI Is Associated with Mid-Term Continence Rates after Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Matthias Müller, et al.
Central European Journal of Urology|November 3, 2021
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional studyFabio Zattoni, Giancarlo Marra, Alexander Kretschmer, et al.
International Urology and Nephrology|February 19, 2021
Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomyMike Wenzel, Felix Preisser, Matthias Mueller, et al.
Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
Pageof 17